Gene therapy clinical trials worldwide to 2007 - an update

被引:421
作者
Edelstein, Michael L.
Abedi, Mohammad R.
Wixon, Jo [1 ]
机构
[1] John Wiley & Sons Ltd, Chichester PO19 8SQ, W Sussex, England
[2] Orebro Univ Hosp, Dept Transfus Med, S-70185 Orebro, Sweden
[3] Hemel Hempstead Hosp, Hemel Hempstead HP2 4AD, England
关键词
SEVERE COMBINED IMMUNODEFICIENCY; SERIOUS ADVERSE EVENT; EUROPEAN-SOCIETY; VECTORS;
D O I
10.1002/jgm.1100
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
To date, over 1340 gene therapy clinical trials have been completed, are ongoing or have been approved worldwide. In 1997 we set up a database to bring together global information on gene therapy clinical trials as comprehensively as possible. The data are compiled and regularly updated from official agency sources, published literature, conference presentations and posters and from information kindly provided by investigators or trial sponsors themselves. This review updates our descriptive overview of the data in 2004 [1], presenting our analysis of the clinical trials that, to the best of our knowledge, have been or are being performed worldwide. As of July 30 2007, we have stored entries on 1309 trials in 28 countries. We have analyzed the geographical distribution of trials, the disease indications (or the proportions to which different vector types other reasons) for trials, and which genes have been transferred. Details of the analyses are used, presented, and our interactive, searchable database can be found on The Journal of Gene Medicine Gene Therapy Clinical Trials Worldwide website at: http://www.wiley.co.uk/genmed/clinical. Copyright (C) 2007 John Wiley & Sons, Ltd.
引用
收藏
页码:833 / 842
页数:10
相关论文
共 31 条
[1]  
[Anonymous], BELGIAN BIOSAFETY SE
[2]  
*ASGT AD HOC COMM, RETR MED GEN TRANS H
[3]   T-LYMPHOCYTE-DIRECTED GENE-THERAPY FOR ADA(-) SCID - INITIAL TRIAL RESULTS AFTER 4 YEARS [J].
BLAESE, RM ;
CULVER, KW ;
MILLER, AD ;
CARTER, CS ;
FLEISHER, T ;
CLERICI, M ;
SHEARER, G ;
CHANG, L ;
CHIANG, YW ;
TOLSTOSHEV, P ;
GREENBLATT, JJ ;
ROSENBERG, SA ;
KLEIN, H ;
BERGER, M ;
MULLEN, CA ;
RAMSEY, WJ ;
MUUL, L ;
MORGAN, RA ;
ANDERSON, WF .
SCIENCE, 1995, 270 (5235) :475-480
[4]   Is it going to be SIN? A European Society of Gene Therapy commentary. Phasing-out the clinical use of non self-inactivating murine leukemia virus vectors: initiative on hold [J].
Buchholz, Christian J. ;
Cichutek, Klaus .
JOURNAL OF GENE MEDICINE, 2006, 8 (10) :1274-1276
[5]   Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease [J].
Cavazzana-Calvo, M ;
Hacein-Bey, S ;
Basile, CD ;
Gross, F ;
Yvon, E ;
Nusbaum, P ;
Selz, F ;
Hue, C ;
Certain, S ;
Casanova, JL ;
Bousso, P ;
Le Deist, F ;
Fischer, A .
SCIENCE, 2000, 288 (5466) :669-672
[6]   Harmful potential of viral vectors fuels doubts over gene therapy [J].
Check, E .
NATURE, 2003, 423 (6940) :573-574
[7]   RETRACTED: Complete and persistent phenotypic correction of phenylketonuria in mice by site-specific genome integration of murine phenylalanine hydroxylase cDNA (Retracted article. See vol. 107, pg. 14514, 2010) [J].
Chen, L ;
Woo, SLC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (43) :15581-15586
[8]  
Couzin J, 2005, SCIENCE, V307, P1028
[9]  
*DEREG, GERMAN SOMATIC GENE
[10]  
DURING MJ, 2006, 36 ANN M SOC NEUR